Inflammatory Bowel Disease: An interview with Dr. John Marshall

Main Article Content

Sadaf Arbab-Tafti
Joseph Di Michele


Dr. John Marshall is a Professor of Medicine, a Full Member of the Farncombe Family Digestive Health Research Institute, and Head of Clinical Research for the Division of Gastroenterology at McMaster University. He is also Chief of Service for Gastroenterology at Hamilton Health Sciences. Dr. Marshall’s clinical and research interests include Inflammatory Bowel Disease (IBD), a group of chronic disorders that cause prolonged inflammation of the gastrointestinal tract. We were able to speak with Dr. Marshall about his clinical and research experiences with IBD and his advice for interested trainees who want to pursue a career in academic medicine.

Article Details

Author Biographies

Sadaf Arbab-Tafti, University of Ottawa

BHSc, MD Candidate (Class of 2018)

Joseph Di Michele, University of Ottawa

BHSc, MD Candidate (Class of 2018)


Marshall JK, Cawdron R, Zealley I, Riddell RH, Somers S, Irvine EJ. Prospective comparison of small bowel meal with pneumocolon versus ileoscopy for diagnosis of ileal Crohn’s disease. Am J Gastroenterol 2004;99:1321-9.

Marshall JK, Blackhouse G, Goeree R, Brazier N, Irvine E, Faulkner L, Dipchand C, O’Brien B. Infliximab for the Treatment of Crohn’s Disease: A systematic Review and Cost-Utility Analysis. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2002. Technology Report no 24.